AB023. S4-3. Down-staging locally advanced disease

Autor Shroff, Rachna T.
Vydáno v Hepatobiliary Surg Nutr (2019)

Consensus Conference on Gallbladder Cancer

Autor Shroff, Rachna T, Knox, Jennifer, Dixon, Elijah
Vydáno v HPB (Oxford) (2015)

Adjuvant/Perioperative Therapy in Pancreatic and Periampullary Cancer

Autor Reilley, Matthew J., Shroff, Rachna, Varadhachary, Gauri R.
Vydáno v Indian J Surg (2015)

Insulin-like Growth Factor Axis Gene Polymorphisms and Clinical Outcome in Pancreatic Cancer

Autor Dong, Xiaoqun, Javle, Milind, Hess, Kenneth R., Shroff, Rachna, Abbruzzese, James L., Li, Donghui
Vydáno 2010

Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers

Autor Mizrahi, Jonathan D, Gunchick, Valerie, Mody, Kabir, Xiao, Lianchun, Surapaneni, Phanikeerthi, Shroff, Rachna T, Sahai, Vaibhav
Vydáno v World J Gastrointest Oncol (2020)

Second-line systemic treatment for advanced cholangiocarcinoma

Autor Rogers, Jane E., Law, Lindsey, Nguyen, Van D., Qiao, Wei, Javle, Milind M., Kaseb, Ahmed, Shroff, Rachna T.
Vydáno v J Gastrointest Oncol (2014)

BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype

Autor Al-Shamsi, Humaid O., Anand, Deepa, Shroff, Rachna T., Jain, Apurva, Zuo, Mingxin, Conrad, Claudius, Vauthey, Jean-Nicolas, Javle, Milind M.
Vydáno v J Gastrointest Oncol (2016)

Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy

Autor Rogers, Jane E., Bolonesi, Ryan M., Rashid, Asif, Elsayes, Khaled M., Elbanan, Mohamed G., Law, Lindsey, Kaseb, Ahmed, Shroff, Rachna T.
Vydáno v J Gastrointest Oncol (2017)

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

Autor Gulhati, Pat, Raghav, Kanwal, Shroff, Rachna, Varadhachary, Gauri, Javle, Milind, Qiao, Wei, Wang, Huamin, Morris, Jeffrey, Wolff, Robert, Overman, Michael J.
Vydáno v Oncologist (2017)

Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemia

Autor Rogers, Jane E., Mizrahi, Jonathan D., Shroff, Rachna T., Nelson, Douglas A., Tu, Janet, Javle, Milind M., Wolff, Robert A., Pant, Shubham
Vydáno v J Gastrointest Oncol (2020)

Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism

Autor Recio-Boiles, Alejandro, Veeravelli, Sumana, Vondrak, Jessica, Babiker, Hani M, Scott, Aaron J, Shroff, Rachna T, Patel, Hitendra, Elquza, Emad, McBride, Ali
Vydáno v World J Gastrointest Oncol (2019)

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Autor Abdel-Wahab, Reham, Varadhachary, Gauri R., Bhosale, Priya R., Wang, Xuemei, Fogelman, David R., Shroff, Rachna T., Overman, Michael J., Wolff, Robert A., Javle, Milind
Vydáno v J Hematol Oncol (2018)

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Autor Javle, Milind M, Shroff, Rachna T, Xiong, Henry, Varadhachary, Gauri A, Fogelman, David, Reddy, Shrikanth A, Davis, Darren, Zhang, Yujian, Wolff, Robert A, Abbruzzese, James L
Vydáno 2010

Next generation sequencing survey of biliary tract cancer (BTC) reveals the association between tumor somatic variants and chemotherapy resistance

Autor Ahn, Daniel H., Javle, Milind, Ahn, Chul W., Jain, Apurva, Mikhail, Sameh, Noonan, Anne M., Wu, Christina, Shroff, Rachna T., Chen, James L., Bekaii-Saab, Tanios
Vydáno v Cancer (2016)

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Autor Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Vydáno v Br J Cancer (2017)

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Autor Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Vydáno v Br J Cancer (2018)

The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy

Autor Shroff, Stuti, Overman, Michael, Rashid, Asif, Shroff, Rachna T., Wang, Hua, Chatterjee, Deyali, Katz, Matthew H., Lee, Jeffrey E., Wolff, Robert A, Abbruzzese, James L., Fleming, Jason B., Wang, Huamin
Vydáno v Arch Pathol Lab Med (2013)

Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma

Autor Fogelman, David, Sugar, Elizabeth A., Oliver, George, Shah, Neeraj, Klein, Alison, Alewine, Christine, Wang, Huamin, Javle, Milind, Shroff, Rachna, Wolff, Robert A., Abbruzzese, James L., Laheru, Daniel, Diaz, Luis A.
Vydáno v Cancer Chemother Pharmacol (2015)

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation

Autor Shroff, Rachna T., Hendifar, Andrew, McWilliams, Robert R., Geva, Ravit, Epelbaum, Ron, Rolfe, Lindsey, Goble, Sandra, Lin, Kevin K., Biankin, Andrew V., Giordano, Heidi, Vonderheide, Robert H., Domchek, Susan M.
Vydáno v JCO Precis Oncol (2018)

Local Therapy Reduces the Risk of Liver Failure and Improves Survival in Patients with Intrahepatic Cholangiocarcinoma: a Comprehensive Analysis of 362 Consecutive Patients

Autor Yamashita, Suguru, Koay, Eugene Jon, Passot, Guillaume, Shroff, Rachna, Raghav, Kanwal P., Conrad, Claudius, Chun, Yun Shin, Aloia, Thomas A., Tao, Randa, Kaseb, Ahmed, Javle, Milind, Crane, Christopher H., Vauthey, Jean-Nicolas
Vydáno v Cancer (2016)